Patents by Inventor Florent C. Bender

Florent C. Bender has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USES OF A DUAL V REGION ANTIBODY-LIKE PROTEIN
    Publication number: 20210221882
    Abstract: Uses of a dual V region antibody-like protein or a fragment of a dual V region antibody-like region.
    Type: Application
    Filed: April 7, 2021
    Publication date: July 22, 2021
    Inventors: Florent C. BENDER, Danxi LI, Anne MINNICH, Amirtha NAADIMUTHU, Ercole RAO, Brian N. SWANSON, Lei TANG, Haixin YU, Otmane BOUSSIF, Sophie CARAYON
  • Uses of a dual V region antibody-like protein
    Patent number: 11008389
    Abstract: Uses of a dual V region antibody-like protein or a fragment of a dual V region antibody-like region.
    Type: Grant
    Filed: July 8, 2016
    Date of Patent: May 18, 2021
    Assignee: SANOFI
    Inventors: Florent C. Bender, Danxi Li, Anne Minnich, Amirtha Naadimuthu, Ercole Rao, Brian N. Swanson, Lei Tang, Haixin Yu, Otmane Boussif, Sophie Carayon
  • Caveolin-1 gene and polypeptide encoded thereby and methods of use thereof
    Publication number: 20040043004
    Abstract: The invention relates to compositions comprising caveolin polypeptides and nucleic acids, and methods of use thereof. The invention is useful in the treatment of non-steroid dependent carcinoma, especially for treatment of gastrointestinal carcinoma. According to the invention, caveolin-1 or the gene encoding caveolin are especially preferred to treat colon carcinoma.
    Type: Application
    Filed: September 3, 2003
    Publication date: March 4, 2004
    Inventors: Florent C. Bender, Marc A. Reymond, Claude Bron, Andrew Quest
  • Caveolin-1 gene and polypeptide encoded thereby and methods of use thereof
    Publication number: 20020065224
    Abstract: The invention relates to compositions comprising caveolin polypeptides and nucleic acids, and methods of use thereof. The invention is useful in the treatment of non-steroid dependent carcinoma, especially for treatment of gastrointestinal carcinoma. According to the invention, caveolin-1 or the gene encoding caveolin are especially preferred to treat colon carcinoma.
    Type: Application
    Filed: October 12, 2001
    Publication date: May 30, 2002
    Inventors: Florent C. Bender, Marc A. Reymond, Claude Bron, Andrew Quest